Studies show that the subclass IV ATAD2 is a generalist facilitator of chromatin dynamics in embryonic stem cells[15], and that bromodomain mutations can disable ATAD2’s ability of promoting cancer cell proliferation[16]. This evidence concerns the gene ATAD2 and cancer.